HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wella

This article was originally published in The Rose Sheet

Executive Summary

Fritz Kuhn, president of Wella's professional division and member of the management board, will retire at year-end after serving 40 years with the German hair care firm, company announces. Effective Jan. 1, Kuhn's responsibilities will be assumed by two regional managers: Michael Uebbing will head the European professional division, while Carsten Fisher will oversee the Americas and Asia. Uebbing and Carsten will report to Wella CEO Heiner Gurtler, who recently assumed responsibilty for both Clairol and Wella's professional businesses, following the firm's acquisition by Procter & Gamble (1"The Rose Sheet" Sept. 8, 2003, p. 4)...

You may also be interested in...



P&G Closes Wella Deal, Will Purchase Additional Shares Sept. 10

Wella AG Management Board Chairman Heiner Gurtler, PhD, will oversee the Clairol and Wella professional businesses in addition to Cosmopolitan Cosmetics in his new role as a president on P&G's Global Leadership Council, the companies said Sept. 2

Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 

Stockwatch: Choppy Waters For Teva And Bausch

After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.

 

 

UsernamePublicRestriction

Register

RS011700

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel